| Title |
Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences
|
|---|---|
| Published in |
Clinical Cancer Research, October 2021
|
| DOI | 10.1158/1078-0432.ccr-21-2404 |
| Pubmed ID | |
| Authors |
Tenna Vesterman Henriksen, Noelia Tarazona, Amanda Frydendahl, Thomas Reinert, Francisco Gimeno-Valiente, Juan Antonio Carbonell-Asins, Shruti Sharma, Derrick Renner, Dina Hafez, Desamparados Roda, Marisol Huerta, Susana Roselló, Anders Husted Madsen, Uffe S. Løve, Per Vadgaard Andersen, Ole Thorlacius-Ussing, Lene Hjerrild Iversen, Kåre Andersson Gotschalck, Himanshu Sethi, Alexey Aleshin, Andres Cervantes, Claus Lindbjerg Andersen |
X Demographics
The data shown below were collected from the profiles of 68 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 11 | 16% |
| United States | 11 | 16% |
| Italy | 4 | 6% |
| Canada | 3 | 4% |
| Australia | 2 | 3% |
| India | 2 | 3% |
| Brazil | 1 | 1% |
| Turkey | 1 | 1% |
| Cayman Islands | 1 | 1% |
| Other | 4 | 6% |
| Unknown | 28 | 41% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 32 | 47% |
| Scientists | 21 | 31% |
| Practitioners (doctors, other healthcare professionals) | 13 | 19% |
| Science communicators (journalists, bloggers, editors) | 2 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 118 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 14 | 12% |
| Student > Ph. D. Student | 12 | 10% |
| Other | 9 | 8% |
| Student > Bachelor | 8 | 7% |
| Student > Master | 8 | 7% |
| Other | 16 | 14% |
| Unknown | 51 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 32 | 27% |
| Biochemistry, Genetics and Molecular Biology | 15 | 13% |
| Agricultural and Biological Sciences | 5 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Nursing and Health Professions | 2 | 2% |
| Other | 6 | 5% |
| Unknown | 55 | 47% |
Attention Score in Context
This research output has an Altmetric Attention Score of 215. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 April 2023.
All research outputs
#181,938
of 25,601,426 outputs
Outputs from Clinical Cancer Research
#78
of 13,273 outputs
Outputs of similar age
#4,960
of 437,437 outputs
Outputs of similar age from Clinical Cancer Research
#6
of 93 outputs
Altmetric has tracked 25,601,426 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,273 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,437 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 93 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.